3.
Funnel plot of comparison: peginterferon plus ribavirin versus non‐pegylated interferon plus ribavirin, outcome: 1.2 Adverse events leading to treatment discontinuation.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.